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Abstract Delayed sternal closure (DSC) is occasionally
adopted after implantation of left ventricular assist device
(LVAD). Recent studies suggest that DSC be used for high
risk group of patients with coagulopathy, hemodynamic
instability or right ventricular failure. However, whether
DSC is efficacious for bleeding complication or right ventricular failure is not known. This study is single center analysis of 52 patients, who underwent LVAD implantation. Of
those 52 patients, 40 consecutive patients underwent DSC
routinely. The sternum was left open with vacuum assist
device after implantation of LVAD. Perioperative outcome
of the patients who underwent routine DSC were compared
with 12 patients who had immediate sternal closure (IC).
Mean Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) level of IC group and DSC
group were 2.7 and 2.6, respectively. Postoperative bleeding
(643 vs. 1469 ml, p < 0.001), duration of inotropic support
(109 vs. 172 h, p = 0.034), and time to extubation (26 vs.
52 h, p = 0.005) were significantly increased in DSC group.
Length of ICU stay (14 vs. 15 days, p = 0.234) and hospital
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stay (28 vs. 20 days, p = 0.145) were similar. Incidence of
right ventricular failure and tamponade were similar in the
two groups. Routine DSC after implantation of an LVAD
did not prove to be beneficial in reducing complications
associated with coagulopathy and hemodynamic instability
including cardiac tamponade or right ventricular failure. We
suggest that DSC be selectively applied for patients undergoing LVAD implant.
Keywords Left ventricular assist device · Delayed sternal
closure · Right ventricular failure · Vacuum assist device ·
Coagulopathy

Introduction
Bleeding after implantation of a left ventricular assist device
(LVAD) is common. Reported incidence of reexploration for
bleeding in this patient population is approximately 30% [1,
21, 2]. For diffuse bleeding in the mediastinum after surgical
hemostasis, the sternum may be left open. Delayed sternal
closure (DSC) may be occasionally adopted for other reasons such as hemodynamic instability, which may be associated with right ventricular failure in this group of patients
with chronic heart failure. However, its indications have not
been clear.
In a recent retrospective study that included 184 patients
who underwent DSC after LVAD implant, DSC was utilized most commonly for coagulopathy, hemodynamic
instability and prior sternotomy. DSC was associated with
longer ICU stay but it was not associated with a significantly
increased risk of death or infection [3]. In another study
that analyzed this patient population, DSC was adopted for
16.8% of those undergoing LVAD with high risk characteristics including higher use of intraoperative blood products,
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longer cardiopulmonary bypass time and right ventricular
assist device (RVAD) support [4]. DSC may be helpful to
reduce morbidity and mortality of these high risk patients.
However, efficacy of DSC, whether DSC reduces bleeding
complication or right ventricular failure, is not known.
In this study, we made a hypothesis that DSC reduces
complications associated with coagulopathy and hemodynamic instability, such as cardiac tamponade or right ventricular failure, for patients undergoing LVAD implantation.
To determine this hypothesis, we performed DSC with a
wound vacuum device routinely after LVAD implant and
closed the chest the following day. The occurrence of bleeding complications, cardiac tamponade, or right ventricular
failure was retrospectively reviewed. The patients with DSC
were compared with those with immediate closure (IC).

Methods
From May 2008 to October 2012, 52 patients underwent
insertion of HeartMate II LVAD (Thoratec Corp., Pleasanton, CA) at our institution. First 12 patients had the chest
closed at the initial operation (IC group, n = 12). Thereafter, 40 patients underwent routine DSC with wound vacuum
device (DSC group, n = 40). All patients enrolled in this
study have given their informed consent, which has been
approved by the institutional committee and this protocol
has been found acceptable by them.
DSC was performed as the following. After insertion
of an LVAD, hemostasis was done and 32 Fr. chest tubes
were placed in the mediastinum inferior and anterior to the
ventricle. The chest was temporarily closed with wound
vacuum device (Kinetic Concepts Inc., San Antonio, TX).
A WhiteFoam® dressing was placed on the anterior wall of
the right ventricle. A black S
 implace® dressing was placed
®
above the WhiteFoam dressing to fill the space between
the sternal edge and the skin level. A thin plastic drape was
placed on the chest and continuous vacuum was started at
25–50 mmHg depending on the amount of bleeding and
chest tube output [5]. Chest tubes were placed on suction
at 20 cmH2O.
Postoperatively continuous intravenous infusion of propofol (0.01–0.05 mg/kg/min) was used to lightly sedate the
patient after recovery of consciousness and gross neurologic
examination. Inotropes and vasopressors regimen included
epinephrine, norepinephrine and milrinone, and were titrated
to maintain mean arterial pressure above 60 mmHg and
adequate urine output. Nitric oxide, started at 20 parts per
million, was used when there were signs of right ventricular
dysfunction including elevation of central venous pressure
greater than 15 mmHg or echocardiographic finding of right
ventricular dysfunction. On postoperative day 1 the chest
was closed in the operating room in the standard fashion.
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All the mediastinal clots were removed. The patients were
mobilized from the bed several hours after extubation. Postoperative antibiotics included vancomycin and rifampin and
piperacillin/tazobactam for 3 days. For patients with penicillin allergy, cefepime instead of piperacillin/tazobactam was
given for 3 days.
Continuous variables were summarized by mean ± standard deviation. Normally distributed continuous variables
were compared across two groups by the independent
samples t test. Non-normally distributed variables were
compared across two groups by the Wilcoxon rank sum
test. Categorical variables were summarized by frequency
and percent. Categorical variables were compared across
groups by the Fisher’s exact test. A p value < 0.05 was considered significant. SPSS™ statistical software version 20
(IBM Corporation, New York, NY) was used for statistical
analysis.

Results
Baseline clinical characteristics of the study patients are
shown in Table 1. INTERMACS profile level was similar
in two groups. Twelve patients (25%) were supported by
mechanical circulatory support before an LVAD insertion
in the study patients, 2 in IC and 10 in DSC. Pre-LVAD
mechanical circulatory support included veno-arterial extracorporeal membranous oxygenation for 3 patients, intraaortic balloon pump (IABP) for 3, HeartMate I (Thoratec
Corp.) for 1, biventricular support with CentriMag (Thoratec
Table 1  Baseline clinical characteristics
All (n = 52) IC (n = 12) DSC (n = 40) p
Age (years)
Female
BSA (m2)
BMI (kg/m2)
Mean INTERMACS
level
Previous sternotomy
Bridging device to
LVAD
Mechanical ventilation
Inotropes
Ischemic cardiomyopathy
DT (vs. BTT)

54.4 ± 12.7
14 (27%)
2.1 ± 0.3
30.1 ± 6.5
3

59.4 ± 11.5
2 (17%)
2.2 ± 0.3
32.2 ± 7.4
2.7

52.9 ± 12.8
12 (30%)
2.1 ± 0.2
30.3 ± 6.3
2.6

0.119
0.475
0.407
0.385
N/A

15 (29%)
12 (23%)

2 (18%)
2 (18%)

13 (33%)
10 (25%)

0.472
0.706

7 (13.5%)

1 (9.1%)

6 (15%)

1.000

21 (41%)
36 (69%)

6 (55%)
6 (50%)

15 (38%)
30 (75%)

0.327
0.153

23 (44%)

4 (33%)

19 (48%)

0.153

BMI body mass index, BSA body surface area, BTT bridge to transplant, DSC delayed sternal closure group, DT destination therapy, IC
immediate sternal closure group, INTERMACS Interagency Registry
for Mechanically Assisted Circulatory Support, LVAD left ventricular
assist device
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Table 2  Preoperative laboratory data
All (n = 52) IC (n = 12) DSC (n = 40) p
Serum Cr (mg/dL) 1.5 ± 0.6
Total Bil. (mg/dL)
2.1 ± 2.9
AST (U/L)
134 ± 486
Albumin (g/dL)
3.1 ± 0.6
Hb (g/dL)
11.3 ± 2.5
Plt (k/μL)
197 ± 113
INR
1.8 ± 1.1

1.7 ± 0.8
1.4 ± 0.5
1.4 ± 1.3
2.3 ± 3.2
32 ± 23
162 ± 547
3.0 ± 0.7
3.1 ± 0.5
10.6 ± 1.9 11.4 ± 2.6
230 ± 194 188 ± 79
1.8 ± 0.7
1.7 ± 1.2

0.132
0.385
0.438
0.524
0.302
0.502
0.964

AST aspartate aminotransferase, Bil bilirubin, Cr creatinine, DSC
delayed sternal closure group, Hb hemoglobin, IC immediate sternal
closure group, INR international normalized ratio, Plt platelet
Table 3  Preoperative hemodynamics
All (n = 52) IC (n = 12) DSC (n = 40) p
HR (/min)
Systolic BP
(mmHg)
Diastolic BP
(mmHg)
CI (l/min/m2)
CVP (mmHg)
PCWP (mmHg)
mPAP (mmHg)

86 ± 22
100 ± 19

83 ± 29
96 ± 13

92 ± 21
102 ± 18

0.274
0.290

59 ± 15

63 ± 14

56 ± 11

0.147

2.0 ± 0.4
19 ± 7
30 ± 8
43 ± 12

2.1 ± 0.6
19 ± 6
29 ± 8
44 ± 11

1.8 ± 0.3
19 ± 7
30 ± 7
43 ± 12

0.052
0.892
0.793
0.793

BP blood pressure, CI cardiac index, CVP central venous pressure,
HR heart rate, mAP mean arterial pressure, mPAP mean pulmonary
arterial pressure, PCWP pulmonary capillary wedge pressure
Table 4  Postoperative clinical
characteristics

OR time (min)
CPB time (min)
Concomitant surgery
Use of factor VII
Postoperative bleeding in the first
24 h (ml)
Postoperative PRBC (unit)
Reexploration for bleeding
Cardiac tamponade
RV failure
Sternal infection
Driveline infection
Inotropic support (h)
Time to extubation (h)
ICU stay (days)
LOS (days)
30 day survival (%)
1 year survival (%)

Corp.) for 1, CentriMag LVAD with IABP for 1, CentriMag
right ventricular assist device (RVAD) with IABP for 1,
CentriMag RVAD for 1 and Impella 5.0 (Abiomed, Danvers, MA) for 1.
Preoperative laboratory data and hemodynamics are
shown in Tables 2 and 3, respectively. No significant difference was identified between the two groups.
Postoperative outcome is summarized in Table 4. Operation time was similar in the two groups. Concomitant surgery was performed in 10 patients (19%), 3 (25%) in IC
and 7 (18%) in DSC, including 4 RVADs, 4 tricuspid valve
repairs, 3 aortic valve replacements, 1 atrial septal defect and
1 patent foramen ovale closure. Use of factor VII was more
common in DSC (p = 0.02). Postoperative bleeding, duration
of inotropic support and time to extubation were significantly increased in DSC. Length of ICU stay and hospital
stay were similar in the two groups. There was no sternal
infection in either group. 30 day and 1 year survival were
similar in the two groups.
Total direct cost per case excluding provider tax is shown
in Table 5. The cost was similar in the two groups. Costs for
surgery and anesthesia were greater in DSC but nursing ICU
cost was lower in DSC.

Discussion
The present study reviewed outcome of patients who underwent DSC after implantation of LVAD. DSC did not reduce
All (n = 52)

IC (n = 12)

DSC (n = 40)

p

321 ± 115
111 ± 51
10 (19%)
16 (31%)
1278 ± 944

332 ± 135
92 ± 22
3 (25%)
0
643 ± 300

318 ± 110
115 ± 55
7 (18%)
16 (41%)
1469 ± 989

0.753
0.322
0.669
0.020
< 0.001

3.3 ± 1.2
2 (4%)
3 (6%)
6 (12%)
0
5 (10%)
158 ± 90
46 ± 42
15 ± 16
22 ± 17
90
74

3.3 ± 1.0
1 (8%)
1 (8%)
0
0
2 (17%)
109 ± 70
26 ± 23
14 ± 8
28 ± 19
92
83

3.2 ± 1.3
1 (3%)
2 (5%)
6 (15%)
0
3 (8%)
172 ± 91
52 ± 45
15 ± 18
20 ± 17
90
70

0.564
0.412
0.553
0.316
N/A
0.325
0.034
0.005
0.234
0.145
1.000
0.693

CPB cardiopulmonary bypass, DSC delayed sternal closure group, IC immediate sternal closure group,
ICU intensive care unit, LOS length of stay, OR operating room, PRBC packed red blood cell, RV right
ventricle
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Table 5  Total cost per case
for implantation of LVAD
(excluding provider tax)
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Period (year)
Total ($, range)
Surgery ($, range)
Anesthesia ($, range)
Nursing ICU ($, range)
Pharmacy ($, range)

IC

DSC

2008–2010
195,171 (189,142–204,053)
107,706 (96,294–121,002)
4155 (3338–4608)
33,155 (27,300–41,842)
13,556 (10,171–19,807)

2011–2012
188,644 (182,357–194,430)
131,601 (128,086–135,117)
4249 (3692–4085)
17,749 (14,033–21,465)
8679 (6719–10,639)

DSC delayed sternal closure group, IC immediate sternal closure group, ICU intensive care unit, $ dollars

incidence of bleeding complications, cardiac tamponade
or right ventricular failure compared to IC. DSC increased
postoperative bleeding, time to extubation but not length of
stay in ICU. Objective of our study was different from other
retrospective studies in which DSC were selectively applied.
Contrary to those studies which identified risk factors that
required DSC, our study attempted to determine efficacy
of DSC.
The sternum may be left open after implantation of LVAD
[2–4]. DSC may be adopted for reasons including bleeding, hemodynamic instability, right ventricular failure and
arrhythmia. When it is done for bleeding, theoretical benefit may include less occurrence of cardiac tamponade by
providing more pericardial space. It also provides benefit
of immediate access for mediastinal exploration if needed
in the ICU for acute change in hemodynamics. Bleeding in
patients with DSC was approximately 820 ml greater than
in patients with IC in the first 24 h in the present study.
Persistent bleeding was frequently noticed from the vacuum
assist device while there was minimal bleeding from the
mediastinal chest tubes. Vacuum assist device was occasionally sucking blood from the bone marrow of the sternum
since the negative pressure applied by the vacuum assist
device was greater than negative pressure applied by 32 Fr.
chest tubes in the mediastinum. In a case study that reported
use of wound vacuum assisted closure to control coagulopathic bleeding in a patient after insertion of LVAD, it was
theorized that a tamponade effect between the mediastinal
tissue and surgical sponges is established by the negative
pressure applied by the chest tubes placed in pleural cavities
bilaterally [6]. In our experience, negative pressure could
not be applied effectively on the entire mediastinum due to
communication with chest tubes and blood loss appeared
to be greater due to bleeding from the sternum. Amount of
blood transfusion was similar in both groups. This may be
explained by our practice of restrictive strategy and minimizing amount of blood transfusion to prevent immunomodulation effect for potential future transplant.
We did not observe significant difference in the incidence
of right ventricular failure in two groups of patients regardless of the sternum was left open or closed at the time of
LVAD implantation; none in IC and 6 patients (15%) in DSC

(p = 0.316). Sternal closure has been shown to result in a significant decrease in cardiac output and diastolic filling even
in patients with good cardiac performance [7]. Furnary et al.
has demonstrated that low cardiac output can be improved
by the opening of the sternum [8]. With this evidence one
may think that leaving the chest open would help prevent
right ventricular failure potentially precipitated by sternal
closure. Right ventricular failure can occur at any time after
insertion of LVAD. Most of RVAD insertion after LVAD
implant occurs in the operating room at the time of LVAD
insertion or within 24 h [9]. In our group of patients with
DSC it was possible that right ventricle, which would have
developed right ventricular failure recovered in the first 24 h
while the chest was open. However, owing to the retrospective nature of the study, our results do not provide more
insight into this issue.
No patients had sternal infection regardless of timing
of chest closure in the current study. DSC as a risk factor
for sternal infection has been debated [10, 11]. In a recent
study that included 5177 patients who underwent cardiac
procedures, 87 patients (1.7%) were managed with DSC.
Incidence of sternal infection was 4.6%. Redo operations,
insertion of VAD, tracheostomy and prolonged open chest
were potential risk factors for sternal infection [11]. On the
other hand, more recently in patients after LVAD implantation, Stulak et al. reported that there was no increase in the
incidence of infectious complication in 184 patients who
had DSC after LVAD implantation [3]. Results in our study
support this finding. Although further studies with more
patients are needed to conclude, DSC can be safely applied
for patients implanted with a VAD without increasing sternal
infectious complications.
In the present study, DSC prolonged time to extubation
since the patients stayed intubated until the chest was closed
the following day. For the same reason DSC prolonged the
use of IV inotropes since weaning of inotropes usually
started after the sternum was closed. It was expected that
this would lead to longer ICU stay in patients after DSC;
however, there was no difference between the two groups.
To minimize ICU stay early extubation and ambulation were
encouraged. Early ambulation, which is 4 to 6 h after extubation, was still possible in patients after DSC. There was
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no difference in overall cost for hospital admission in two
groups. It was attributed to early mobilization in the postoperative management of patients after DSC. At the same time
management of LVAD patients in the ICU became more
efficient as more VAD implantations were performed.
Our study did not prove routine DSC to be advantageous
and suggests that DSC be selectively applied. Question
remains in terms of which patients should have DSC after
implantation of LVAD. There are patients who continue to
bleed after insertion of LVAD, especially in patients with
previous sternotomy or on platelet inhibitors. These bleeding patients with cardiomyopathy are susceptible to hemodynamic instability and threshold to reexploration should
be low. Although DSC was not found useful to decrease the
incidence of cardiac tamponade or right ventricular failure
in our experience, there is still an added advantage of allowing immediate access to the mediastinum for evacuation of
blood and clots for cardiac tamponade and for application of
internal defibrillation if needed in ICU. In studies that analyzed patients in whom DSC was adopted after LVAD insertion, indication was mainly for coagulopathy. Two recent
studies described use of DSC in this patient population [3,
4]. In Stulak’s study, reasons for DSC included coagulopathy in 155 patients (84%), hemodynamic instability in 103
(56%), significant isolated right ventricular dysfunction in
15 (8%). The other study that analyzed use of DSC after
LVAD implant did not mention reason for DSC but identified predictors of DSC including preoperative glycoprotein
IIb/IIIa inhibitor, more intraoperative use of PRBC and
tricuspid valve procedure [4]. For coagulopathic patients
DSC actually increases bleeding but facilitates subsequent
reexploration. For patients with tenuous right ventricular
function DSC will be needed if the patient does not tolerate
sternal approximation, however, DSC itself will not reduce
incidence of postoperative right ventricular dysfunction.
Limitations
Our case series is limited by a small number of patients and
retrospective assessment of data and it is subject to all limitations inherent in such studies. In this observational study,
sample sizes of patients with DSC and IC were not balanced.
This sample size imbalance was partly due to increasing case
volume during the study period as the number of referrals to
our mechanical circulatory support program increased. DSC
was introduced to our practice as the program was increasing case volume. As case volume increased the patients who
needed LVAD became more heterogeneous, although two
groups are statistically similar in collected variables. Lack
of balance in sample size may make finding a significant
difference more difficult. Failure to detect a difference may
be a result of low power due to small sample size. Brain
natriuretic peptide measurement was not routinely done
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early in the study period and was not shown in this study.
Echocardiographic finding was not shown in this study since
diagnosis of right ventricular failure after VAD implantation
was made clinically including hemodynamic data. From our
visual observation, increase in blood loss in DSC was attributed to continuous marrow bleed from the sternum; however,
blood loss was measured as a combined output from the
wound vacuum device and the chest tubes. Separate measurement of two drainage sources was not performed in this
study. To more strictly compare the amount of bleeding, all
the blood products given for bleeding should be measured.
In our study, only the amount of packed red blood cell and
factor VII were included as parameters.

Conclusions
Routine DSC after implantation of an LVAD did not prove
to be beneficial in reducing complications associated with
coagulopathy and hemodynamic instability including cardiac tamponade or right ventricular failure. Although it
increased postoperative bleeding and time to extubation, it
did not increase hospital length of stay, incidence of sternal infection or driveline infection. We suggest that DSC be
selectively applied for patients undergoing LVAD implant.
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